Home
Journal Information
About
Aims and Scope
Contacts and Editorial Office
Editorial Board
Editor in Chief
Publisher
Conflicts of Interest
Editorial Policies
Publication Ethics
Nickan Research Institute policy
DISCLAIMER
Open Access
Journal Issues
Current Issue
In Press
Archive
Guidelines
For Authors
For Authors-New
For Reviewers
Peer Review Process in JRIP
Peer Review Process flowchart in JRIP
Authors agreement form
Checklist for review
Editorial Workflow
Publication Ethics and Malpractice Statement
Human and animal right
Informed Consent
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
eISSN
:
2345-2781
Submit Your Paper
Editorial Board
Aims and Scope
Publisher
Publication Fee
Contact Us
Archive
Indexing Information
Member of
Follower of
2024, Vol 13, No. 3
×
Journal of Renal Injury Prevention
Chief Editor: Azar Baradaran
Review
1. Surveying the relationship between Gly1057Asp polymorphism of IRS-2 gene and susceptibility to type 2 diabetes; a systematic review and meta-analysis study
Faezeh Kiani
, Fatemeh Sayehmiri
, Ali Hasanpour Dehkordi
, Morteza Motedayen*
J Renal Inj Prev
. 2019;8(4): 263-270.
doi:
10.15171/jrip.2019.50
Scopus ID:
85076315326
Article
PDF
XML
Cited By:
1
0
×
Surveying the relationship between Gly1057Asp polymorphism of IRS-2 gene and susceptibility to type 2 diabetes; a systematic review and meta-analysis study
Review
2. Acute kidney injury in hospitalized COVID-19 patients in Iran; a systematic review and meta-analysis
Alireza Saghafi
, Mohammad Aghaali
, Hossein Saghafi*
J Renal Inj Prev
. 2021;10(2): e09.
doi:
10.34172/jrip.2021.09
Scopus ID:
85103104754
Article
PDF
Suppl 1
XML
Cited By:
8
4
×
Acute kidney injury in hospitalized COVID-19 patients in Iran; a systematic review and meta-analysis
Review
3. Sodium-glucose co-transporter 2 inhibitors (SGLT2i); as a preventive factor of kidney failure in patients with type 2 diabetes; a meta-analysis of randomized controlled trials
Dorsa Jahangiri
, Udit Narayan Padhi
, Henu Kumar Verma
, Bhaskar VKS Lakkakula
, Rohollah Valizadeh
, Hamid Nasri*
J Renal Inj Prev
. 2021;10(4): e35.
doi:
10.34172/jrip.2021.35
Scopus ID:
85115654690
Article
PDF
XML
Cited By:
1
2
×
Sodium-glucose co-transporter 2 inhibitors (SGLT2i); as a preventive factor of kidney failure in patients with type 2 diabetes; a meta-analysis of randomized controlled trials